We are live on ! Find out more
CMIIU

CM Life Sciences II Inc. Unit
CMIIU

Delisted

CMIIU was delisted on the 1st of September, 2021.

Back to rankings

38 hedge funds and large institutions have $237M invested in CM Life Sciences II Inc. Unit in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% less capital invested

Capital invested by funds: $290M → $237M (-$52.9M)

34% less funds holding

Funds holding: 58 → 38 (-20)

36% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 11

65% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 31

Holders
38
Holders Change
-20
Holders Change %
-34.48%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
7
Reduced
11
Closed
31
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$37.9M
2
Marshall Wace
Marshall Wace
United Kingdom
+$10.5M
3
Ameriprise
Ameriprise
Minnesota
+$9.53M
4
WMSA
Weiss Multi-Strategy Advisers
New York
+$7.07M
5
HC
Hourglass Capital
Texas
+$2.53M

Top Sellers

Rank Fund Capital Flow
1
SM
SB Management
United Arab Emirates
-$30.9M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$16M
3
PTC
Petrus Trust Company
Texas
-$10.2M
4
SHCM
Sachem Head Capital Management
New York
-$10.2M
5
Blackstone Inc
Blackstone Inc
New York
-$7.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
HM
51
HealthCor Management
New York
– -$2.22M -173,563 Closed
ESCM
52
Echo Street Capital Management
New York
– -$1.77M -138,305 Closed
CCM
53
Context Capital Management
California
– -$1.61M -125,500 Closed
DKCM
54
Davidson Kempner Capital Management
New York
– -$1.59M -125,000 Closed
Wellington Management Group
55
Wellington Management Group
Massachusetts
– -$1.5M -116,889 Closed
MC
56
Maverick Capital
Texas
– -$1.28M -100,000 Closed
GGHC
57
Gilder Gagnon Howe & Co
New York
– -$954K -74,570 Closed
BL
58
Bleichroeder LP
New York
– -$897K -70,100 Closed
Susquehanna International Group
59
Susquehanna International Group
Pennsylvania
– -$786K -61,382 Closed
MFM
60
MHR Fund Management
New York
– -$640K -50,000 Closed
Citadel Advisors
61
Citadel Advisors
Florida
– -$491K -38,357 Closed
BCM
62
Beryl Capital Management
California
– -$436K -34,035 Closed
ACM
63
Arrow Capital Management
New York
– -$320K -25,000 Closed
SC
64
Shay Capital
New York
– -$256K -20,000 Closed
WAM
65
Wolverine Asset Management
Illinois
– -$241K -18,885 Closed
AA
66
AQR Arbitrage
Connecticut
– -$128K -10,000 Closed
UBS Group
67
UBS Group
Switzerland
– -$48K -3,735 Closed
Rockefeller Capital Management
68
Rockefeller Capital Management
New York
– +$666 +50 New
1 2
3

CMIIU Hedge Fund Activity: Q2 2021 in Review

38 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in CM Life Sciences II Inc. Unit (CMIIU) for Q2 2021, worth a combined $237M — down 18% from $290M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of CMIIU and 11 opened new positions — a net loss of 20 holders — while 11 trimmed existing stakes and 7 added.

The largest buyer was ARK Investment Management, opening a new position worth an estimated $37.9M. The largest seller was SB Management, cutting an estimated $30.9M.

  • 38 institutional investors held CM Life Sciences II Inc. Unit (CMIIU) as of Q2 2021, down from 58 in Q1 2021.
  • Funds reported $237M of CM Life Sciences II Inc. Unit stock for Q2 2021, down 18% quarter-over-quarter.
  • 11 funds opened new CM Life Sciences II Inc. Unit positions in Q2 2021 and 31 closed out, a net change of -20 holders.
  • The largest CM Life Sciences II Inc. Unit buyer in Q2 2021 was ARK Investment Management, an estimated $37.9M added.
  • The largest CM Life Sciences II Inc. Unit seller in Q2 2021 was SB Management, an estimated $30.9M sold.

Based on aggregated 13F filings for Q2 2021.